Caspase: The Executioner of Cell Death | Community Health

Caspase, a family of cysteine proteases, plays a crucial role in programmed cell death, or apoptosis, and inflammation. First discovered in 1993 by Robert Horvitz and colleagues, caspase has been extensively studied for its involvement in various cellular processes, including the regulation of apoptosis, inflammation, and cell differentiation. The caspase cascade, a series of caspase activations, is triggered by pro-apoptotic signals, leading to the execution of cell death. However, dysregulation of caspase activity has been implicated in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. With a vibe score of 8, caspase research has garnered significant attention in recent years, with over 10,000 publications in 2020 alone. As researchers continue to unravel the complexities of caspase biology, the potential for therapeutic interventions targeting caspase activity has become increasingly promising, with several caspase inhibitors currently in clinical trials.